» Articles » PMID: 34685464

Bioactive Natural Compounds with Antiplatelet and Anticoagulant Activity and Their Potential Role in the Treatment of Thrombotic Disorders

Overview
Journal Life (Basel)
Specialty Biology
Date 2021 Oct 23
PMID 34685464
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Natural anticoagulant drugs can be obtained from plants, rich in secondary bioactive metabolites which, in addition to being effective antioxidants, also possess anticoagulant and antiplatelet properties and, for this reason, can be excellent candidates for the treatment of thrombotic diseases. This review reports an overview of the hemostatic process and thrombotic disorders together with data on plants, more and less common from around the world, containing bioactive compounds characterized by antiplatelet and anticoagulant activity. The reported literature was obtained from Medline, PubMed, Elsevier, Web of Science, Google Scholar considering only articles in the English language, published in peer-reviewed journals. The number of citations of the articles and the impact factor of the journals were other parameters used to select the scientific papers to be included in the review. The analysis of the literature data selected demonstrates that many plants' bioactive compounds show antiplatelet and anticoagulant activity that make them potential candidates to be used as new natural compounds able to interfere with both primary and secondary hemostasis. Moreover, they could be used together with anticoagulants currently administered in clinical practice to increase their efficacy and to reduce complications in the treatment of thrombotic disorders.

Citing Articles

Unrevealing the mechanisms behind the cardioprotective effect of wheat polyphenolics.

Chakraborty P, Dewanjee S Arch Toxicol. 2024; 98(11):3543-3567.

PMID: 39215839 DOI: 10.1007/s00204-024-03850-y.


Non-clinical investigations about cytotoxic and anti-platelet activities of gamma-terpinene.

Souza R, Pimentel V, de Sousa R, Sena E, da Silva A, Dittz D Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(10):8145-8160.

PMID: 38801455 DOI: 10.1007/s00210-024-03173-w.


Natural Phenolic Compounds with Antithrombotic and Antiplatelet Effects: A Drug-likeness Approach.

Fernandes D, Gomes A, da Silva C, de Medeiros Henriques I, Barros de Menezes R, Scotti M Curr Med Chem. 2024; 31(26):4138-4159.

PMID: 38375850 DOI: 10.2174/0109298673268452231108061008.


Phytochemical Profiling and Antioxidant Capacity of Traditional Plants, Northern Thailand.

Jeeno P, Yadoung S, Yana P, Hongsibsong S Plants (Basel). 2023; 12(23).

PMID: 38068593 PMC: 10707735. DOI: 10.3390/plants12233956.


Ex Vivo Antiplatelet and Thrombolytic Activity of Bioactive Fractions from the New-Fangled Stem Buds of L. with Simultaneous GC-MS Examination.

Kumar S, Arif M, Kamal M, Jawaid T, Khan M, Mukhtar B Molecules. 2023; 28(9).

PMID: 37175328 PMC: 10179924. DOI: 10.3390/molecules28093918.


References
1.
Schreuder M, Reitsma P, Bos M . Blood coagulation factor Va's key interactive residues and regions for prothrombinase assembly and prothrombin binding. J Thromb Haemost. 2019; 17(8):1229-1239. PMC: 6851895. DOI: 10.1111/jth.14487. View

2.
Tankersley D, Finlayson J . Kinetics of activation and autoactivation of human factor XII. Biochemistry. 1984; 23(2):273-9. DOI: 10.1021/bi00297a016. View

3.
Jagroop I . Plant extracts inhibit ADP-induced platelet activation in humans: their potential therapeutic role as ADP antagonists. Purinergic Signal. 2013; 10(2):233-9. PMC: 4040171. DOI: 10.1007/s11302-013-9393-0. View

4.
Applegate J, Gronefeld D . Factor V Leiden. Radiol Technol. 2019; 90(3):259-273. View

5.
Debbie Jiang M, Alfred Ian Lee M . Thrombotic Risk from Chemotherapy and Other Cancer Therapies. Cancer Treat Res. 2019; 179:87-101. DOI: 10.1007/978-3-030-20315-3_6. View